AMC1 CAT.GEN.MPA.170(c) Psychoactive substances

• ED Decision 2018/012/R found in: Air Operations (965/2012) Part-ARO Part-ORO Part-CAT Part-SPA Part-NCC Part-NCO Part-SPO (Sep 2023)

AMC1 CAT.GEN.MPA.170(c) Psychoactive substances ED Decision 2018/012/R OBJECTIVE, TRANSPARENT AND NON-DISCRIMINATORY TESTING PROCEDURE The operator’s objective, transparent and non-discriminatory testing procedure should specify: (a) means to ensure confidentiality and protection of data; (b) the responsibilities of the person carrying out a test, which should be in accordance with national legislation; (c) the timing and suitable locations for testing; (d) that the body responsible for testing should be an independent, accredited body using standard guidelines on psychoactive substance testing in line with national legislation; (e) the testing process, and in particular: (1) the psychoactive substances to be tested for; (2) the applicable national legislation and use of recognised quality standards applied to the testing methodology; (3) initial screening and confirmation methods used; and (4) handling of test results, which should be conducted by impartial and trained personnel, in order to ensure adherence to the procedure, to determine the true positives and to prevent false positives; (f) applicable limits applying to psychoactive substance tests; (g) the process to be followed in case of a confirmed positive test result; and (h) the internal appeal process. AMC1 CAT.GEN.MPA.170(c) Psychoactive substances ED Decision 2018/012/R OBJECTIVE, TRANSPARENT AND NON-DISCRIMINATORY TESTING PROCEDURE The operator’s objective, transparent and non-discriminatory testing procedure should specify: (a) means to ensure confidentiality and protection of data; (b) the responsibilities of the person carrying out a test, which should be in accordance with national legislation; (c) the timing and suitable locations for testing; (d) that the body responsible for testing should be an independent, accredited body using standard guidelines on psychoactive substance testing in line with national legislation; (e) the testing process, and in particular: (1) the psychoactive substances to be tested for; (2) the applicable national legislation and use of recognised quality standards applied to the testing methodology; (3) initial screening and confirmation methods used; and (4) handling of test results, which should be conducted by impartial and trained personnel, in order to ensure adherence to the procedure, to determine the true positives and to prevent false positives; (f) applicable limits applying to psychoactive substance tests; (g) the process to be followed in case of a confirmed positive test result; and (h) the internal appeal process. ##### AMC1 CAT.GEN.MPA.170(c) Psychoactive substances *ED Decision 2018/012/R* **OBJECTIVE, TRANSPARENT AND NON-DISCRIMINATORY TESTING PROCEDURE** The operator’s objective, transparent and non-discriminatory testing procedure should specify: (a) means to ensure confidentiality and protection of data; (b) the responsibilities of the person carrying out a test, which should be in accordance with national legislation; (c) the timing and suitable locations for testing; (d) that the body responsible for testing should be an independent, accredited body using standard guidelines on psychoactive substance testing in line with national legislation; (e) the testing process, and in particular: (1) the psychoactive substances to be tested for; (2) the applicable national legislation and use of recognised quality standards applied to the testing methodology; (3) initial screening and confirmation methods used; and (4) handling of test results, which should be conducted by impartial and trained personnel, in order to ensure adherence to the procedure, to determine the true positives and to prevent false positives; (f) applicable limits applying to psychoactive substance tests; (g) the process to be followed in case of a confirmed positive test result; and (h) the internal appeal process.